SCHEMBL19818

SCHEMBL19818

COCCOC(=O)C1(OCCOC)CCC(c2cc(NCOCC[Si](C)(C)C)n3nccc3n2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 4/20 0.41
CDK9 P50750 3/20 0.31
CDK2 P24941 2/20 0.31
CDK7 P50613 2/20 0.31
CDK13 Q14004 1/20 0.31
CDK12 Q9NYV4 1/20 0.31
PRKAB2 O43741 1/20 0.30
PRKAG1 P54619 1/20 0.30
PRKAA2 P54646 1/20 0.30
PRKAA1 Q13131 1/20 0.30
PRKAG3 Q9UGI9 1/20 0.30
PRKAG2 Q9UGJ0 1/20 0.30
PRKAB1 Q9Y478 1/20 0.30
CCNT1 O60563 2/20 0.30
DGAT1 O75907 1/20 0.30
GSK3B P49841 1/20 0.30
MAPKAPK2 P49137 1/20 0.30
CCNH P51946 1/20 0.30
CCNE1 P24864 1/20 0.30
KCNN3 Q9UGI6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL40556 0.87 HSD17B10 (0.33) GSK3B
SCHEMBL21222 0.85 CRHR1 (0.31)
SCHEMBL42979 0.82 CDK2 (0.43) PDE10ACDK9CDK2CDK7CDK13
SCHEMBL47762 0.81 CHEK1 (0.38) CDK2DGAT1
SCHEMBL30813 0.78 CRHR1 (0.31)
SCHEMBL10209999 0.78 PDE10A (0.53) PDE10ACDK9CDK2CDK7CDK13
SCHEMBL39693 0.78 PDE10A (0.50) PDE10ACDK9CDK2CDK7CDK13
SCHEMBL47770 0.77 PDE10A (0.49) PDE10ACDK9CDK2CDK7CDK13
SCHEMBL10210928 0.77 PDE10A (0.49) PDE10ACDK9CDK2CDK7CDK13
SCHEMBL15007172 0.74 KDM4E (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2608669-B1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS MERCK SHARP & DOHME (US) 2016-06-22 EP disclosed
EP-2608668-B1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN MERCK SHARP & DOHME (US) 2016-06-01 EP disclosed
WO-2012027234-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN SCHERING CORPORATION (US) 2012-03-01 WO disclosed
WO-2012027236-A1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS SCHERING CORPORATION (US) 2012-03-01 WO disclosed